Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Vaccines|August 28, 2025
Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines 2024, 12, 974Kristen Feemster, William P Hausdorff, Natalie Banniettis, et al.
Vaccines|September 28, 2024
Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine DevelopmentKristen Feemster, William P Hausdorff, Natalie Banniettis, et al.
Vaccine|August 10, 2024
Attitudes of pregnant women in the Dominican Republic towards a future maternal Group B Streptococcus vaccineMegan J Job, Diane Kim, Francia Acosta, et al.
Journal of the Pediatric Infectious Diseases Society|November 20, 2015
Burden of Influenza-Related Hospitalizations and Attributable Mortality in Pediatric Acute Lymphoblastic LeukemiaGrace E Lee, Brian T Fisher, Rui Xiao, et al.
Pediatrics|May 8, 2013
Effectiveness of decision support for families, clinicians, or both on HPV vaccine receiptAlexander G Fiks, Robert W Grundmeier, Stephanie Mayne, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 3, 2025
Health state utilities associated with invasive pneumococcal disease, pneumonia, and recurrent acute otitis media in young childrenLouis S Matza, Timothy A Howell, Bianca Chun, et al.
The Pediatric Infectious Disease Journal|August 11, 2023
Safety and Immunogenicity of V114 in Preterm Infants: A Pooled Analysis of Four Phase Three StudiesTimothy J Chapman, Shrita M Patel, Sheryl A Flores, et al.
AIDS (London, England)|March 20, 2023
A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIVMarissa Wilck, Shaun Barnabas, Kulkanya Chokephaibulkit, et al.
Blood Advances|November 16, 2022
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) studyCharles T Quinn, Richard T Wiedmann, Daniel Jarovsky, et al.
The Lancet. Infectious Diseases|April 15, 2022
Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational studyWinston E Abara, Kyle T Bernstein, Felicia M T Lewis, et al.
Pageof 4